IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

 

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
D

Appropriateness of Biomarker Selection for Durvalumab Consolidation Therapeutic Decision-Making in Stage III NSCLC

By IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage FEATURING David Gandara
By IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage FEATURING David Gandara
0 views
March 20, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
Videos
11:37
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

ADCs in SCLC

Feat. A. Chiang
14:31
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Placing ADCs in the Lung Cancer Treatment Algorithm

Feat. J. Reuss
11:58
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

ALK Resistance in NSCLC

Feat. A. Qin
06:09
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

MET Exon 14 Skipping Mutation in NSCLC: An Analysis by Specific Muta…

Feat. J. Marks
06:36
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Appropriateness of Biomarker Selection for Durvalumab Consolidation …

Feat. D. Gandara
10:20
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Rare EGFR Mutations in NSCLC: Do We Know Enough to Treat Them Differ…

Feat. X. Le
19:53
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Consolidation Strategies in SCLC: IO and Radiation

Feat. N. Abdel Karim
14:23
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Updates on the Use of Consolidation IO in NSCLC Based on Biomarker S…

Feat. E. Vokes
13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

Feat. E. Rodriguez
10:14
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Targeted Therapy in Consolidation Setting for Locally Advanced NSCLC

Feat. J. West
19:59
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Therapies for Early Stage NSCLC: Adjuvant Chemo/IO

Feat. J. Spicer
18:53
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Tissue Based Predictors of Immunotherapy

Feat. N. Vokes